Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
- Therapeutic Areas
Our expertise in the industry
Funding for US science agencies will stay flat or even increase over the next several months, under a US$1-trillion spending deal announced on 30 April. The plan devised by Congress, which covers t...
US President Donald Trump has signed a revised version of his controversial travel ban. The policy, issued on 6 March, exempts citizens of Iraq and people who were issued US visas before 27 January...
US drug approvals are on track to drop by more than half in 2016 compared to 2015. The agency had approved 19 new drugs this year as of 9 December, putting it on track for its lowest yearly tally s...
Republican businessman and reality-television star Donald Trump will be the United States’ next president. Although science played only a bit part in this year’s dramatic, hard-fought campaign, man...
Progress is driven by innovation. When it comes to developing novel medications and the...
The HIV-1 treatment market for naïve and experienced patients is evolving consistently....
The Pharmaceuticals segment of the Healthcare Industry has a significant market across ...
Von Willebrand disease is a type of blood disorder that causes the blood to clot improp...
Advances in genetics research have sparked a surge in interest in gene therapy in derma...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
